Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Alliance to develop allergy treatments established by Maxygen and ALK-Abello

Feb. 23, 2001

Preparation and use of potassium channel blockers described by NeuroSearch

Feb. 22, 2001

Cognetix awarded Phase I SBIR grant to study potential asthma treatment

Feb. 22, 2001

Novartis receives FDA approval for Foradil Aerolizer for asthma maintenance therapy

Feb. 20, 2001

VLA-4 antagonists with oral activity emerge from Daiichi/Pharmacopeia collaboration

Feb. 19, 2001

Antihistaminic equivalence of cetirizine and levocetirizine demonstrated in healthy volunteers

Feb. 19, 2001

New therapeutic option for allergies available from UCB in Germany

Feb. 16, 2001

Dyax and Debiopharm move cystic fibrosis treatment into phase II

Feb. 14, 2001

Patent issued to Welfide covers new IL-4/IL-5 production inhibitors

Feb. 14, 2001

Arriva to develop ilomastat as respiratory disease treatment

Feb. 13, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...